US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Abbott Laboratories

us-stock
To Invest in {{usstockname}}
us-stock
$125.35 -0.0082(-0.82%) ABT at 04 Dec 2025 04:24 PM Medical Devices
Lowest Today 125.21
Highest Today 127.53
Today’s Open 126.28
Prev. Close 126.32
52 Week High 139.33
52 Week Low 109.21
Day’s Range: Low 125.21 High 127.53
52-Week Range: Low 109.21 High 139.33
1 day return -
1 Week return -2.89
1 month return -0.38
3 month return -5.64
6 month return -5.79
1 year return +8.02
3 year return +18.85
5 year return +16.14
10 year return -

Institutional Holdings

Vanguard Group Inc 9.93

BlackRock Inc 8.12

State Street Corp 4.50

Capital Research & Mgmt Co - Division 3 3.46

Vanguard Total Stock Mkt Idx Inv 3.14

Vanguard 500 Index Investor 2.47

Capital Research Global Investors 2.40

JPMorgan Chase & Co 2.26

Geode Capital Management, LLC 2.20

Morgan Stanley - Brokerage Accounts 2.02

Wellington Management Company LLP 1.44

NORGES BANK 1.28

Fidelity 500 Index 1.27

Bank of America Corp 1.25

Northern Trust Corp 1.21

SPDR® S&P 500® ETF 1.21

iShares Core S&P 500 ETF 1.20

American Funds Washington Mutual A 1.09

Capital Group Wash Mutual Invtrs Comp 1.09

Wells Fargo & Co 0.99

American Funds Invmt Co of Amer A 0.92

Capital Group Investment Co of Amer Comp 0.92

Vanguard Value Index Inv 0.89

Goldman Sachs Group Inc 0.87

Massachusetts Financial Services Company 0.82

State Farm Mutual Automobile Ins Co 0.78

FMR Inc 0.78

Charles Schwab Investment Management Inc 0.76

Ameriprise Financial Inc 0.75

UBS Asset Mgmt Americas Inc 0.73

The Health Care Select Sector SPDR® ETF 0.68

American Funds American Mutual A 0.65

Capital Group American Mutual Comp 0.65

American Funds Capital World Gr&Inc A 0.61

Capital Group World Growth & Inc Cmp 0.61

Vanguard Institutional Index I 0.60

Vanguard Dividend Appreciation ETF 0.54

American Funds Capital Income Bldr A 0.53

State St S&P 500® Indx SL Cl III 0.53

American Funds American Balanced A 0.50

Market Status

Strong Buy: 12

Buy: 7

Hold: 9

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 219854.78 M

PB Ratio 4.3685

PE Ratio 15.8693

Enterprise Value 227801.00 M

Total Assets 81414.00 M

Volume 4918925

Company Financials

Annual Revenue FY24:41950000000 41950.0M, FY23:39959000000 39959.0M, FY22:43653000000 43653.0M, FY21:43075000000 43075.0M, FY20:34608000000 34608.0M

Annual Profit FY24:23244000000 23244.0M, FY23:21947000000 21947.0M, FY22:24511000000 24511.0M, FY21:24538000000 24538.0M, FY20:19605000000 19605.0M

Annual Net worth FY24:13402000000 13402.0M, FY23:5162000000 5162.0M, FY22:6933000000 6933.0M, FY21:7071000000 7071.0M, FY20:4495000000 4495.0M

Quarterly Revenue Q3/2025:11369000000 11369.0M, Q2/2025:11142000000 11142.0M, Q1/2025:10358000000 10358.0M, Q4/2024:10974000000 10974.0M, Q3/2024:10635000000 10635.0M

Quarterly Profit Q3/2025:6338000000 6338.0M, Q2/2025:6288000000 6288.0M, Q1/2025:5444000000 5444.0M, Q4/2024:6032000000 6032.0M, Q3/2024:5937000000 5937.0M

Quarterly Net worth Q3/2025:1644000000 1644.0M, Q2/2025:1779000000 1779.0M, Q1/2025:1325000000 1325.0M, Q4/2024:9229000000 9229.0M, Q3/2024:1646000000 1646.0M

Fund house & investment objective

Company Information Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Organisation Medical Devices

Employees 114000

Industry Medical Devices

CEO Mr. Robert B. Ford

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right